CY1614A - Cephalosporin salts and injectable compositions - Google Patents

Cephalosporin salts and injectable compositions

Info

Publication number
CY1614A
CY1614A CY1614A CY161492A CY1614A CY 1614 A CY1614 A CY 1614A CY 1614 A CY1614 A CY 1614A CY 161492 A CY161492 A CY 161492A CY 1614 A CY1614 A CY 1614A
Authority
CY
Cyprus
Prior art keywords
injectable compositions
cephalosporin salts
cephalosporin
salts
injectable
Prior art date
Application number
CY1614A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1614A publication Critical patent/CY1614A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
CY1614A 1985-08-05 1992-07-10 Cephalosporin salts and injectable compositions CY1614A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (1)

Publication Number Publication Date
CY1614A true CY1614A (en) 1992-07-10

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1614A CY1614A (en) 1985-08-05 1992-07-10 Cephalosporin salts and injectable compositions

Country Status (34)

Country Link
JP (1) JPH0615548B2 (it)
KR (1) KR930003121B1 (it)
AR (1) AR243894A1 (it)
AT (1) AT390957B (it)
AU (1) AU597262B2 (it)
BE (1) BE905219A (it)
CA (1) CA1284994C (it)
CH (1) CH675581A5 (it)
CS (2) CS276717B6 (it)
CY (1) CY1614A (it)
DD (2) DD254941A5 (it)
DE (1) DE3626375A1 (it)
DK (1) DK162053C (it)
EG (1) EG18003A (it)
ES (1) ES2002112A6 (it)
FI (1) FI84484C (it)
FR (1) FR2585705B1 (it)
GB (1) GB2179936B (it)
GR (1) GR862055B (it)
HK (1) HK99691A (it)
HU (1) HU196602B (it)
IE (1) IE59222B1 (it)
IL (1) IL79608A (it)
IT (1) IT1197067B (it)
LU (2) LU86540A1 (it)
MY (1) MY102212A (it)
NL (1) NL8601991A (it)
OA (1) OA08672A (it)
PT (1) PT83134B (it)
SE (1) SE469633B (it)
SG (1) SG79791G (it)
SU (1) SU1516013A3 (it)
YU (1) YU45793B (it)
ZA (1) ZA865842B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
EP0321562B1 (en) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
JP4616844B2 (ja) 2003-12-23 2011-01-19 サンド・ゲーエムベーハー セファロスポリン合成に使用するための中間体の生成プロセス
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
YU137186A (en) 1987-12-31
CH675581A5 (it) 1990-10-15
AT390957B (de) 1990-07-25
FR2585705A1 (fr) 1987-02-06
AU597262B2 (en) 1990-05-31
ZA865842B (en) 1987-04-29
HK99691A (en) 1991-12-13
FI84484C (fi) 1991-12-10
OA08672A (en) 1989-03-31
IE59222B1 (en) 1994-01-26
DE3626375A1 (de) 1987-02-12
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
BE905219A (fr) 1987-02-04
CS276717B6 (en) 1992-08-12
YU45793B (sh) 1992-07-20
IT1197067B (it) 1988-11-25
HUT41802A (en) 1987-05-28
MY102212A (en) 1992-05-15
FI863155A (fi) 1987-02-06
IT8621409A1 (it) 1988-02-04
FR2585705B1 (fr) 1989-01-13
PT83134B (pt) 1989-07-31
DK371886A (da) 1987-02-06
DK162053B (da) 1991-09-09
IL79608A (en) 1991-07-18
DD254941A5 (de) 1988-03-16
CS276849B6 (en) 1992-08-12
DK371886D0 (da) 1986-08-04
DK162053C (da) 1992-02-10
HU196602B (en) 1988-12-28
SE8603308D0 (sv) 1986-08-04
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
JPS62103090A (ja) 1987-05-13
SU1516013A3 (ru) 1989-10-15
ES2002112A6 (es) 1988-07-16
NL8601991A (nl) 1987-03-02
PT83134A (en) 1986-09-01
GB2179936A (en) 1987-03-18
LU86540A1 (fr) 1987-03-06
DD268395A5 (de) 1989-05-31
GB8618989D0 (en) 1986-09-17
GR862055B (en) 1986-12-24
IT8621409A0 (it) 1986-08-04
EG18003A (en) 1991-08-30
SG79791G (en) 1991-11-15
ATA211086A (de) 1990-01-15
IE862078L (en) 1987-02-05
AR243894A1 (es) 1993-09-30
FI863155A0 (fi) 1986-08-01
FI84484B (fi) 1991-08-30
AU6069486A (en) 1987-02-12
SE469633B (sv) 1993-08-09
GB2179936B (en) 1989-04-26
IL79608A0 (en) 1986-11-30
LU88574I2 (fr) 1995-03-01
CA1284994C (en) 1991-06-18

Similar Documents

Publication Publication Date Title
ZA89407B (en) Cephalosporin salts and injectable compositions
NZ215333A (en) Cephem compounds and pharmaceutical compositions
GB2179936B (en) Cephalosporin salts and injectable compositions
GB8519452D0 (en) Injectable solutions
PH23045A (en) Cephem derivative and composition containing said compound
NZ212320A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ215717A (en) Cephalosporin derivatives
GR861727B (en) 5-substituted-6-aminopyridine derivatives composition and uses
EP0209751A3 (en) New cephalosporin derivatives and bactericides containing the same
NZ214048A (en) Cephalosporins and pharmaceutical compositions
EP0230052A3 (en) Immunoamplifiers and related compositions
PH23442A (en) Cephalosporin derivatives and salts thereof
GB8511207D0 (en) Particulate composition
NZ210761A (en) Cephalosporin derivatives and pharmaceutical compositions
IL88959A (en) Cephalosporin salts and injectable compositions
IL74822A (en) Cephalosporin derivatives and salts thereof and their preparation
PH21201A (en) Cephalosporin derivatives and salts thereof
NZ216624A (en) Cephalosporins and pharmaceutical compositions
HUT44607A (en) Emulsifyer-anti-corrosive additive composition
ZA862347B (en) Cephalosporin derivatives
IL78351A0 (en) Cephalosporin derivatives
IE850040L (en) Cephalosporin derivatives
IL79200A0 (en) Cephalosporin derivatives
IE850448L (en) Cephalosporin derivatives
IE841527L (en) Cephalosporin salts